Clonal origin analysis of secondary lesions reveals metastatic predominance and a role for FHL2 in head and neck squamous cell carcinomas
Cellular Oncology · 31.10.2026
DOI: 10.1007/s13402-026-01316-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 31.10.2026. Verfasst von Meixuan Wan und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Medical Award Foundation, N10 Found project of Harbin Medical University Cancer Hospital, National Nature Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Beijing Medical Award Foundation
- N10 Found project of Harbin Medical University Cancer Hospital
- National Nature Science Foundation of China
- High Level Talent Program in Medicine-National Outstanding Young Physician Program
- Heilongjiang Province Innovation Base Award Project
- Wujieping grants
Zitieren
APA
Wan, M., Yang, X., Deng, S., Yang, S., Guo, C., Zhao, X., Ju, R., Kuang, H., Cheng, Y., Guo, Y., & Meng, H. (2026). Clonal origin analysis of secondary lesions reveals metastatic predominance and a role for FHL2 in head and neck squamous cell carcinomas. Cellular Oncology. https://doi.org/10.1007/s13402-026-01316-0
Vancouver
Wan M, Yang X, Deng S, Yang S, Guo C, Zhao X, et al. Clonal origin analysis of secondary lesions reveals metastatic predominance and a role for FHL2 in head and neck squamous cell carcinomas. Cellular Oncology. 2026. doi:10.1007/s13402-026-01316-0
BibTeX
@article{Wan2026,
author = {Wan, Meixuan and Yang, Xinxin and Deng, Shuzhe and Yang, Shuo and Guo, Chenxu and Zhao, Xiangyu and Ju, Ran and Kuang, Hong and Cheng, Yalin and Guo, Ying and Meng, Hongxue},
title = {Clonal origin analysis of secondary lesions reveals metastatic predominance and a role for FHL2 in head and neck squamous cell carcinomas},
journal = {Cellular Oncology},
year = {2026},
doi = {10.1007/s13402-026-01316-0}
}
EUVIMED